Red River Bancshares Adds New Board Members

By Chris Stiles • Friday, May 29 09:49 • Permanent Link

Red River Bancshares has reshaped its board, retiring longtime director Kirk D. Cooper and adding two new members, A. Peyton Bush, IV and R. Chance DeWitt, M.D.

Cooper stepped down May 7 after serving on the company’s board since 1998 and on Red River Bank’s board since 1999. That marks a 28-year run with the bank and a 27-year tenure with the holding company.

Bush and DeWitt were elected May 28 to fill the vacancy created by Cooper’s retirement and another director resignation last year. With the additions, Red River Bancshares now has 10 directors.

Bush brings investment management experience. He is chief investment officer of Bollinger Enterprises, where he oversees investment activities and asset allocation, and previously held roles at LongueVue Capital, Highland Capital Management and JP Morgan Securities.

DeWitt brings healthcare leadership. He is a cardiothoracic and vascular surgeon at Lourdes Cardiovascular Clinic and serves as director of cardiac rehabilitation and medical director of the Structural Heart Program at Our Lady of Lourdes Heart Hospital.

Red River Bank, the company’s banking subsidiary, operates 28 banking centers across Louisiana, plus three combined loan and deposit production offices in New Orleans, Lafayette and Shreveport. Its footprint spans seven Louisiana markets: Central, Northwest, Capital, Southwest, Northshore, Acadiana and New Orleans. The market has reacted to these announcements by moving the company's shares 1.04% to a price of $92.05. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.